Medtech in a Minute: Abbott's Big FDA Approval, and More
The news you need. In one minute or less.
The news you need. In one minute or less.
An FTC request stalls Boston Scientific's acquisition of Axonics.
The New Brunswick, NJ-based company could strengthen its position in the cardiovascular intervention market with this $13.1 billion acquisition.